153 related articles for article (PubMed ID: 32935910)
1. Onychomadesis following COVID-19 infection: Is there a relationship?
Senturk N; Ozdemir H
Dermatol Ther; 2020 Nov; 33(6):e14309. PubMed ID: 32935910
[No Abstract] [Full Text] [Related]
2. Isolated maculopapular eruption localized to head and neck: A cutaneous sign of COVID-19 infection.
Farabi B; Atak MF
Dermatol Ther; 2020 Nov; 33(6):e14468. PubMed ID: 33112023
[No Abstract] [Full Text] [Related]
3. Cutaneous lesions and COVID-19: Cystic painful lesion in a case with positive SARS-CoV-2.
Goudarzi S; Dehghani Firouzabadi F; Dehghani Firouzabadi M; Rezaei N
Dermatol Ther; 2020 Nov; 33(6):e14266. PubMed ID: 32882081
[No Abstract] [Full Text] [Related]
4. Cutaneous Hyperaesthesia in SARS-CoV-2 Infection: Rare but not Unique Clinical Manifestation.
Krajewski PK; Maj J; Szepietowski JC
Acta Derm Venereol; 2021 Jan; 101(1):adv00366. PubMed ID: 33320278
[No Abstract] [Full Text] [Related]
5. Urticaria in an infant with SARS-CoV-2 positivity.
Proietti I; Mambrin A; Bernardini N; Tolino E; Balduzzi V; Maddalena P; Marchesiello A; Michelini S; Volpe S; Skroza N; Potenza C
Dermatol Ther; 2020 Nov; 33(6):e14043. PubMed ID: 32697027
[No Abstract] [Full Text] [Related]
6. Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study.
Català A; Galván-Casas C; Carretero-Hernández G; Rodríguez-Jiménez P; Fernández-Nieto D; Rodríguez-Villa A; Navarro-Fernández Í; Ruiz-Villaverde R; Falkenhain-López D; Llamas-Velasco M; Carnero-Gonzalez L; García-Gavin J; Baniandrés O; González-Cruz C; Morillas-Lahuerta V; Cubiró X; Figueras I; Selda-Enriquez G; Fustà-Novell X; Roncero-Riesco M; Burgos-Blasco P; Romaní J; Solà-Ortigosa J; García-Doval I
Dermatol Ther; 2020 Nov; 33(6):e14170. PubMed ID: 32779280
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Endothelial Dysfunction and Complement Deposition in COVID-19.
Tammaro A; Adebanjo GAR; Del Nonno F; Pezzuto A; Ramirez-Estrada S; Parisella FR; Rello J; Scarabello A
Am J Dermatopathol; 2021 Mar; 43(3):237-238. PubMed ID: 33055532
[No Abstract] [Full Text] [Related]
8. Cutaneous manifestations of COVID-19: A case report and a new finding from Egypt.
Farouk S; Sadek A
Dermatol Ther; 2020 Nov; 33(6):e14038. PubMed ID: 32691948
[No Abstract] [Full Text] [Related]
9. Alopecia areata in a patient with SARS-Cov-2 infection.
Sgubbi P; Savoia F; Calderoni O; Longo R; Stinchi C; Tabanelli M
Dermatol Ther; 2020 Nov; 33(6):e14295. PubMed ID: 32909635
[No Abstract] [Full Text] [Related]
10. Enanthem in Patients With COVID-19 and Skin Rash.
Jimenez-Cauhe J; Ortega-Quijano D; de Perosanz-Lobo D; Burgos-Blasco P; Vañó-Galván S; Fernandez-Guarino M; Fernandez-Nieto D
JAMA Dermatol; 2020 Oct; 156(10):1134-1136. PubMed ID: 32667631
[TBL] [Abstract][Full Text] [Related]
11. Case report: SARS-CoV-2-induced urticaria or just a concomitance?
Fida M; Mala R; Pupo L; Dibra A; Nasto K
Dermatol Ther; 2020 Nov; 33(6):e14250. PubMed ID: 32860461
[TBL] [Abstract][Full Text] [Related]
12. Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment.
Martinez MA
Front Immunol; 2021; 12():635371. PubMed ID: 33777024
[No Abstract] [Full Text] [Related]
13. SARS-CoV-2 virus infection: Targets and antiviral pharmacological strategies.
Campos DMO; Fulco UL; de Oliveira CBS; Oliveira JIN
J Evid Based Med; 2020 Nov; 13(4):255-260. PubMed ID: 33058394
[No Abstract] [Full Text] [Related]
14. An EUA for sotrovimab for treatment of COVID-19.
Med Lett Drugs Ther; 2021 Jun; 63(1627):97-xx98. PubMed ID: 34181630
[No Abstract] [Full Text] [Related]
15. Cutaneous manifestations in hospitalized patients diagnosed as COVID-19.
Askin O; Altunkalem RN; Altinisik DD; Uzuncakmak TK; Tursen U; Kutlubay Z
Dermatol Ther; 2020 Nov; 33(6):e13896. PubMed ID: 32579756
[TBL] [Abstract][Full Text] [Related]
16. Colchicin treatment of COVID-19 presenting with cutaneous rash and myopericarditis.
Recalcati S; Piconi S; Franzetti M; Barbagallo T; Prestinari F; Fantini F
Dermatol Ther; 2020 Nov; 33(6):e13891. PubMed ID: 32584431
[No Abstract] [Full Text] [Related]
17. An EUA for bamlanivimab and etesevimab for COVID-19.
Med Lett Drugs Ther; 2021 Apr; 63(1621):49-50. PubMed ID: 33830966
[No Abstract] [Full Text] [Related]
18. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
Million M; Roussel Y; Gautret P; Raoult D
Int J Antimicrob Agents; 2021 Jan; 57(1):106240. PubMed ID: 33408019
[No Abstract] [Full Text] [Related]
19. Coronavirus disease 2019 and epidermolysis bullosa: Report of three cases.
Abdollahimajd F; Youssefian L; Pourani MR; Vahidnezhad H; Uitto J
Dermatol Ther; 2020 Nov; 33(6):e14194. PubMed ID: 32794270
[No Abstract] [Full Text] [Related]
20. Urticaria in the times of COVID-19.
Kaushik A; Parsad D; Kumaran MS
Dermatol Ther; 2020 Nov; 33(6):e13817. PubMed ID: 32531079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
